Search Results - "Birzu, C."

Impact of anti-PD-1 therapy in a melanoma patient with paraneoplastic anti-ITPR1 encephalitis by Brunet-Possenti, F., Birzu, C., Deschamps, L., Hacein-Bey-Abina, S., Psimaras, D., Chrétien, P.

Get full text

Prognosis of glioblastoma patients improves significantly over time interrogating historical controls by Thomas-Joulié, A., Tran, S., El Houari, L., Seyve, A., Bielle, F., Birzu, C., Lozano-Sanchez, F., Mokhtari, K., Giry, M., Marie, Y., Laigle-Donadey, F., Dehais, C., Houillier, C., Psimaras, D., Alentorn, A., Laurenge, A., Touat, M., Sanson, M., Hoang-Xuan, K., Kas, A., Rozenblum, L., Habert, M.-O., Nichelli, L., Leclercq, D., Galanaud, D., Jacob, J., Karachi, C., Capelle, L., Carpentier, A., Mathon, B., Belin, L., Idbaih, A.

“…Glioblastoma (GBM) is the most common devastating primary brain cancer in adults. In our clinical practice, median overall survival (mOS) of GBM patients seems…”
Get full text

Meningiomas: A review of current knowledge by Boetto, J, Birzu, C, Kalamarides, M, Peyre, M, Sanson, M

“…Meningiomas are the most frequent among intracranial tumors, and represent more than 30% of primitive central nervous system neoplasms. Arising from the…”
Get full text

Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents by Bompaire, F., Birzu, C., Bihan, K., Desestret, V., Fargeot, G., Farina, A., Joubert, B., Leclercq, D., Nichelli, L., Picca, A., Tafani, C., Weiss, N., Psimaras, D., Ricard, D.

“…•The continuous development of new oncological treatments have led to the emergence of new neurological side effects.•The neurological side effects of…”
Get full text

Neurotoxicity in patients with CNS lymphomas treated with CAR‐T cell therapy. A LOC network study by Tost, H. Hernandez, Weiss, N., Choquet, S., Ribeiro, M., Birzu, C., Le Guennec, L., Shor, N., Morel, V., Solorzano, S., Souchet, L., Boussen, I., Roos‐Weil, D., Friser, V., Miranda, N., Le Garff‐Tavernier, M., Soussain, C., Hoang‐Xuan, K., Psimaras, D., Houillier, C.

Get full text

292P Androgen receptor signalling is associated with resistance to temozolomide and tumour growth in glioblastoma by Birzu, C., Boussier, J., Belin, L., Lemaire, N., Da Costa Pereira, T., Mokhtari, K., Verreault, M., Idbaih, A.

Get full text

Accelerated cortical atrophy and hypometabolism following axicabtagene ciloleucel treatment: A case report by Martin, M., Nichelli, L., Habert, M.O., Loiseau, C., Psimaras, D., Birzu, C.

Get full text

P07.01.B ANDROGEN RECEPTOR SIGNALING MODULATES BOTH TUMOR AND IMMUNE CELLS IN GLIOBLASTOMA AND IMPACTS GLIOBLASTOMA GROWTH by Birzu, C, Scherer, L, Chaskis, E, Boussier, J, Belin, L, Quissac, E, Da Costa Perreira, T, Daddi, K, Scuderi, S, Laurenge, A, Castro Vega, L, Mokhtari, K, Tran, S, Mathon, B, Verreault, M, Idbaih, A

“…Abstract BACKGROUND Glioblastoma (GBM) is more frequent (sex ratio M:F=1.6) and exhibits worse prognosis in males compared to females suggesting a role of the…”
Get full text

P10.17.B Androgen receptor signalling has independent prognostic value and is associated with resistance to temozolomide and tumour growth in glioblastoma by Birzu, C, Boussier, J, Belin, L, Da Costa Pereira, T, Quissac, E, Zerara, M, Lemaire, N, Mokhtari, K, Verreault, M, Idbaih, A

“…Abstract Background The spectrum of sex differences in glioblastoma (GBM) is a rising topic. GBM is more frequent (sex ratio M:F=1.6) and seem to have worse…”
Get full text

P11.52.A Peripheral neuropathies after BRAF and/or MEK inhibitors treatment: a pharmacovigilance study by Picca, A, Birzu, C, Berzero, G, Sanchez-Pena, P, Gaboriau, L, Vidil, F, Lenglet, T, Tafani, C, Ricard, D, Psimaras, D, Bihan, K

“…Abstract Background BRAF (BRAFi) and MEK inhibitors (MEKi) demonstrated significant efficacy in the treatment of BRAF-activated tumours, firstly melanoma…”
Get full text

P10.06 Stiff limb syndrome associated to anti NMDA-R antibodies by Birzu, C, Jaume, L, Rostomashvilli, S, Honnorat, J, Berzero, G, Psimaras, D

“…Abstract BACKGROUND Stiff person spectrum disorder is a group of rare conditions clinically characterized by the core symptoms of fluctuating muscular…”
Get full text

P11.66.A Immune checkpoint inhibitors related peripheral nerve disorders: clinical and electrophysiological particularities by Birzu, C, Farina, A, Pegat, A, Devic, P, Lenglet, T, Viala, K, Debs, R, Fargeot, G, Picca, A, Le Guennec, L, Mongin, M, Villette, B, Joubert, B, Maisonobe, T, Psimaras, D

“…Abstract Background The immune-checkpoint inhibitors (ICIs) announced a new era in cancer treatment allowing long-term survival in advanced cancers. However,…”
Get full text

KS02.5.A THE ONCOMETABOLITE D-2-HYDROXYGLUTARATE PROMOTES DNA HYPERMETHYLATION AT LINEAGE-SPECIFIC ENHANCERS CONTROLLING MICROGLIAL ACTIVATION IN IDH-MUTATED GLIOMAS by Laurenge, A, Pugliese, P, Mathon, B, Richard, Q, Jouannet, S, Hayat, Y, Scuderi, S, Marijon, P, Labreche, K, Alentorn, A, Verreault, M, Idbaih, A, Birzu, C, Huillard, E, Pottier, N, Desmons, A, Fayache, I, Kaas, G A, Kingsley, P J, Marnett, L J, Duplus, E, El-Habr, E, Salas, L A, Mokhtari, K, Tran, S, Suvà, M L, Iavarone, A, Ceccarelli, M, Touat, M, Bielle, F, Mallat, M, Sanson, M, Castro-Vega, L

“…Abstract BACKGROUND Resident microglia are highly plastic myeloid cells. Their phenotype and immune response are determined by the microenvironment…”
Get full text

JS03.6.A NEUROTOXICITY IN PATIENTS WITH CNS LYMPHOMAS TREATED WITH CAR T CELL THERAPY. A LOC NETWORK STUDY by Hernández-Tost, H, Weiss, N, Choquet, S, Ribeiro, M, Birzu, C, Le Guennec, L, Schor, N, Morel, V, Solorzano, S, Souchet, L, Boussen, I, Roos-Weil, D, Friser, V, Miranda, N, Le Garff-Tavernier, M, Soussain, C, Hoang-Xuan, K, Psimaras, D, Houillier, C

“…Abstract BACKGROUND CAR-T cell therapy represents one of the major progress of the last years in aggressive B-cell lymphomas. Its use in central nervous system…”
Get full text

P14.126 radiation-induced optic neuropathy by Thomas, A, Birzu, C, Feuvret, L, Noël, G, Hoang-Xuan, K, Savatosky, J, Ricard, D, Psimaras, D

“…Abstract BACKGROUND Optic neuropathy is an inflammation of the optic nerve leading to a rapidly progressive visual loss. Most frequent etiologies are multiple…”
Get full text

OS9.7 Telomere length, TERTp mutation and ALT status in adult diffuse gliomas by Birzu, C, Hillairet, A, Giry, M, Grandin, N, Verrelle, P, Mokhtari, K, Marie, Y, Hoang-Xuan, K, Delattre, J, Idbaih, A, Charbonneau, M, Sanson, M, Alentorn, A

“…Abstract BACKGROUND The current classification of adult diffuse gliomas integrates two alternative telomere maintenance mechanisms: reactivation of telomerase…”
Get full text

Les méningiomes : mise au point sur les connaissances actuelles by Boetto, J., Birzu, C., Kalamarides, M., Peyre, M., Sanson, M.

“…Les méningiomes sont les tumeurs intracrâniennes les plus fréquentes, représentant plus d’un tiers des tumeurs primitives du système nerveux central…”
Get full text

OS9.1 Clinical significance of hypermutation in gliomas by Touat, M, Li, Y, Boynton, A, Spurr, L, Iorglescu, B, Geduldig, J, Birzu, C, Lim Fat, M, Santagata, S, Coulet, F, Beuvon, F, Mokhtari, K, Giry, M, Block, S, Guillerm, E, Carpentier, A, Huang, R, Delattre, J, Hoang-Xuan, K, Sanson, M, Duval, A, Cherniack, A, Reardon, D, Wen, P, Idbaih, A, Marabelle, A, Bandopadhayay, P, Beroukhim, R, Bielle, F, Ligon, K

“…Abstract BACKGROUND Among patients with glioma, little is known about the clinical significance of hypermutation. We sought to define the determinants of…”
Get full text

Meningiomas: A review of current knowledge by Boetto, J, Birzu, C, Kalamarides, M, Peyre, M, Sanson, M

Get full text

Profil métabolique cérébral des encéphalites auto-immunes séropositives en TEP FDG by Bergeret, S., Birzu, C., Meneret, P., Giron, A., Navarro, V., Psimaras, D., Kas, A.

“…Le diagnostic des encéphalites auto-immunes (EAI) est difficile compte tenu d’une clinique polymorphe et d’un manque de biomarqueurs pour son diagnostic…”
Get full text